ClinicalTrials.Veeva

Menu

Testing the Capability of the Smart Underwear Device to Detect Increased Microbiome Activity Following Lactose Consumption

University of Maryland logo

University of Maryland

Status

Enrolling

Conditions

Lactose Intolerance, Adult Type

Treatments

Device: Wear smart underwear
Dietary Supplement: Sucrose
Dietary Supplement: Lactose

Study type

Interventional

Funder types

Other

Identifiers

NCT06724705
Smart Underwear Lactose

Details and patient eligibility

About

The goal of this Interventional study is to validate the Smart Underwear device's ability to detect lactose intolerance by comparing its results to self-reported symptoms in adult participants aged 18 and above, divided equally between self-reported lactose-tolerant and lactose-intolerant individuals.

The main questions it aims to answer are:

Can the Smart Underwear device reliably measure flatus events after lactose consumption? Does the Microbiome Activity Index differentiate between responses to lactose and sucrose consumption?

Researchers will compare participants consuming lactose (experimental arm) with their results after consuming sucrose (placebo arm) to see if the device detects increased flatus events and higher Microbiome Activity Index values in the lactose arm.

Participants will:

  • Follow a low-fiber/low-FODMAP diet for four days.
  • Record meals using a food log and a custom smartphone app.
  • Wear the Smart Underwear device for 8 hours daily for three days.
  • Fast for 12 hours overnight, consume 20 grams of either lactose or sucrose dissolved in water, and continue fasting for an additional 4 hours.
  • Fast for 12 hours overnight, consume 20 grams of the carbohydrate they did not consume the first time (lactose or sucrose) dissolved in water, and continue fasting for an additional 4 hours.
  • Complete digestive symptom surveys after each carbohydrate intake.

The randomized crossover design ensures that participants consume both lactose and sucrose on separate days, with blinding maintained for both participants and researchers.

Enrollment

100 estimated patients

Sex

All

Ages

18+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Has no gastrointestinal disorders
  • Not consuming any prescribed medications
  • Willing and able to consume sucrose and lactose
  • Determined to be lactose tolerant or lactose intolerant after completing an eligibility survey

Exclusion criteria

  • Younger than 18 years old
  • Diagnosed with or suspected to have the following conditions: diabetes, prediabetes, high blood sugar, IBD, SIBO, or a food allergy to sucrose or lactose
  • Experience gastrointestinal pain, bloating, or diarrhea when consuming garlic, onions, or leeks
  • Routinely experience constipation or painful constipation
  • Have ever had an anaphylactic reaction after eating or drinking anything

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

100 participants in 2 patient groups, including a placebo group

Placebo
Placebo Comparator group
Description:
Participants consume sucrose and wear the Smart Underwear device
Treatment:
Dietary Supplement: Sucrose
Device: Wear smart underwear
Experimental
Experimental group
Description:
Participants consume lactose and wear the Smart Underwear device
Treatment:
Dietary Supplement: Lactose
Device: Wear smart underwear

Trial contacts and locations

1

Loading...

Central trial contact

Brantley Hall, PhD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems